S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease

por Parenti, Giancarlo, Porto, Caterina, Acampora, Emma, Avolio, Valeria, Gagliardo, Cristina, Rosa, Margherita, Fecarotta, Simona, Andria, Generoso
Publicado 2011

The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts

por Porto, Caterina, Cardone, Monica, Fontana, Federica, Rossi, Barbara, Tuzzi, Maria Rosaria, Tarallo, Antonietta, Barone, Maria Vittoria, Andria, Generoso, Parenti, Giancarlo
Publicado 2009

Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts

por Cardone, Monica, Porto, Caterina, Tarallo, Antonietta, Vicinanza, Mariella, Rossi, Barbara, Polishchuk, Elena, Donaudy, Francesca, Andria, Generoso, De Matteis, Maria Antonietta, Parenti, Giancarlo
Publicado 2008

Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase

por Iacono, Roberta, Minopoli, Nadia, Ferrara, Maria Carmina, Tarallo, Antonietta, Damiano, Carla, Porto, Caterina, Strollo, Sandra, Roig-Zamboni, Véronique, Peluso, Gianfranco, Sulzenbacher, Gerlind, Cobucci-Ponzano, Beatrice, Parenti, Giancarlo, Moracci, Marco
Publicado 2021

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease

por Tarallo, Antonietta, Damiano, Carla, Strollo, Sandra, Minopoli, Nadia, Indrieri, Alessia, Polishchuk, Elena, Zappa, Francesca, Nusco, Edoardo, Fecarotta, Simona, Porto, Caterina, Coletta, Marcella, Iacono, Roberta, Moracci, Marco, Polishchuk, Roman, Medina, Diego Luis, Imbimbo, Paola, Monti, Daria Maria, De Matteis, Maria Antonietta, Parenti, Giancarlo
Publicado 2021